![cbac-cccb](/web/20071116065611im_/http://cbac-cccb.ca/epic/home.nsf/images/ah_top_image.jpg/$FILE/ah_top_image.jpg)
|
![](/web/20071116065611im_/http://cbac-cccb.ca/epic/home.nsf/images/spacer.gif/$FILE/spacer.gif) |
Home
Publications
Research
2000
Status Report and Commentary on the International Debate Over the Precautionary Principle
based on the International Conference on Biotechnology in the Global
Economy: Science and the Precautionary Principle, 22-23 September
2000, Kennedy School of Government at Harvard University
Prepared for
The Canadian Biotechnology Advisory Committee Project Steering
Committee On Genetically Modified Foods
By Marc Saner
December 2000
Table of Contents
-
Conference Goals
-
Limitations of this Conference
-
The Main Issues
-
Diverging Use of the PP in Different
Countries
-
Effect on Lesser Developed Nations
-
Outlook and Recommendation
-
Conference Goals
The following text in sans-serif typeface is the Conference
Summary provided by the organizers on their website. I added
boldface to one pertinent passage which I will discuss in the
next section.
“Harvard University’s” Center for
International Development (CID) and the
Belfer Center for Science and International Affairs
(BCSIA) hosted an "International Conference on
Biotechnology in the Global Economy: Science and the
Precautionary Principle" on 22-23 September 2000 at the
Kennedy School of Government, Harvard University. The
conference was part of a series of events aimed at exploring
key policy issues related to biotechnology and globalization.
The safe use of modern agricultural biotechnology has become
one of the most contentious debates worldwide. There is
general agreement on the need to ensure the safety of
biotechnology products through effective risk assessment,
management and communication. However, countries differ on
how to reflect these measures in public policy. Some
require that "sound science" is used as a basis for
restricting trade in products that pose a threat to the
environment and human health. Others, however, argue for
"precautionary measures" that allow policy action
to be taken in the absence of full scientific
certainty. In 1992, the United Nations
Conference on Environment and Development (UNCED)
adopted Principle 15 which states that "where there are
threats of serious or irreversible damage, lack of full
scientific certainty shall not be used as a reason for
postponing cost-effective measures to prevent environmental
degradation." A version of this principle was recently
incorporated into the Biosafety Protocol to the
Convention on Biological Diversity. There is
considerable controversy on the meaning, scope, context and
application of the precautionary principle in international
trade and environmental management.The aim of the conference
was to explore the policy and practical implications of the
use of the precautionary principle in the field of
biotechnology. The conference covered: (a) theoretical,
historical and cultural aspects of the principle; (b)
previous applications in international environmental and
trade law (c) the implications of various definitions for the
principle’’s use in international discussions and
negotiations; and (d) social, economic and political
implications of the principle in developed and developing
countries.The conference was held in two plenary sessions and
two parallel discussion sessions. Its results contributed to
current efforts to develop research activities, provide
training and promote policy dialogue and awareness on the
safe use of biotechnology.”
-
Limitations of this Conference
This conference is the second in a series of highly informative
and successful conferences on modern biotechnology. The
conference provided a very broad overview of the issues. It was
attended by many influential individuals and featured broad
international representation. It is important to note, however,
that the debate over the precautionary principle (PP) is very
complex and no resolution on this issue can be expected from
such a short event.
The debate over the meaning and implementation of the
precautionary principle is now so extensive that it has become a
profession to some. The flurry of activities encompass a number
of dedicated conferences, entire books and countless academic
and popular articles. The “Viewpoints” posted to the
conference website alone represent approximately 25,000 words
and could be bound into a small book ( http://www.cid.harvard.edu/cidbiotech/comments/).
The materials distributed at the conference further indicate how
widespread the debate is. Finally, dedicated conferences on the
topic have become frequent. I did not make an effort to track
all the recent conferences on the PP, but here is a list of
three events I came across by chance within the last few days:
-
Four days after the conference the following event took
place: “The Precautionary Principle: Agriculture and
Biotechnology,” a Capitol Hill Briefing sponsored by
the International Consumers for Civil Society.
-
In the latest newsletter of the Society of Environmental
Toxicology and Chemistry, I noted a lengthy discussion on the
precautionary principle which was the topic of one of the
closing sessions of the Third World Congress of this society
(Brighton, UK, May 2000)
-
In an electronic newsletter I, received I noted that in June
1999, the Harvard Center for Risk Analysis sponsored a policy
workshop on the topic: “The Precautionary Principle:
Refine It or Replace It?”
These shall suffice to provide a context in which to view the
conference goals stated above.
Another limitation of the conference lies perhaps in the way the
issue was framed. The juxtaposition of “sound
science” vs. the “precautionary principle,” as
outlined in the conference description quoted above, may be
misleading. It seems to imply that “sound science”
is free of the use of the PP and that the PP does not contain
sound science. At the conference, however, it was made plain by
experts of the contemporary scientific and legal situation in
the United States that the precautionary principle has been used
for many years within a “sound-science approach”
before it became an issue of debate. It was also made plain by
advocates of the PP that they are very keen on discussing risk
issues in terms of testable hypotheses (which could be addressed
by sound science). Therefore, I would argue, the juxtaposition
of “sound science” vs. “precautionary
principle” does not describe the diverging positions well.
Moreover, it may promote the use of rhetoric because neither
side wants to be considered “careless” or
“unscientific.” Instead, all sides aspire to combine
accurate facts and reasonable caution.
-
The Main Issues
It is a major challenge to frame this debate. I tried hard to
give all sides a fair hearing (and feel qualified to do so as
both scientist and ethicist, and being both Canadian and
European) but I found that the majority of speakers used
rhetoric to promote their diverging outlooks on biotechnology.
But this is not only an issue of rhetorical communicators. At
the conference it became obvious that it is also an issue of
biased audiences: their responses were often emotional and not
always justified by the content of the presentations.
In many ways, the first session was the most interesting and
showed the fundamental conflicts very clearly. It was also
controversial with highly animated debates following the
presentations.
In the introduction, Calestous Juma, the conference organizer,
indicated that his team has identified 14 different definitions
of the PP (later speakers argued that this was too low an
estimate). As a consequence, agreeing over the precise meaning
of the PP did not look like a feasible goal right at the onset
of the conference.
Jeffrey Sachs, Director of the Center for International
Development at Harvard made a strong case for the use of
biotechnology worldwide and for an implementation of the PP in a
narrow risk assessment context. He argued that progress in
science and technology is crucially important
for the future of lesser developed countries. Technology
transfer and adoption of biotechnology are required, if poor
nations are not to stay outside of a new economy. He also
predicted that biotechnology will continue in the US, take off
in China and India, and be adopted by South America. Africa he
sees as undecided. He argued for the autonomy of nations when it
comes to risk acceptance and called the PP hopelessly vague if
not quantified.
The next speaker, John Holdren of the Belfer Centre for Science
and International Affairs, Harvard University, took a very
different stance. He argued that not everything can be
quantified nor monetized and warned that overstating
expectations can be very dangerous (rf. nuclear power). He also
mentioned the increasing abundance of industry / academic
relationships is a major issue in the context of biotechnology.
Konrad Von Moltke of the International Institute for Sustainable
Development looked into the institutional context. He stated
that Article 20 of the GATT is inadequate and represents the
reason for the inability of the WTO to move on the issue. The
international divergence in the use of the PP is a result. He
illustrated that we have already many examples where the PP has
been operationalized. He also gave historic examples for
environmental issues which were successfully addressed despite
the use of apparently inadequate management systems. As a
consequence he is not in the least worried about the vagueness
of the PP. He pointed out that risk assessment is an invention
of the United States which is tied to “inconsistencies of
the US government structure” and stated that France
“needs risk assessment like a hole in the head”. His
final advice was to refrain from defining the PP in terms of
biotechnology only.
Carloyn Raffensperger, Science and Environmental Health Network,
provided an NGO perspective. She promoted the widely used
“Wingspread Definition” of the PP in which she has a
personal stake (from a 1998 conference). She argued for a
broader approach to the assessment of risk as outlined in Mary
O’Brien’s new book (Making Better Environmental
Decisions, MIT Press, 2000). General principles are to
shift questions towards a more holistic approach and to set
broad societal goals. She also argued that the PP is not in
conflict with science but that it requires more and different
science than traditionally used. In her view the PP is an
overarching principle that should be used very early in the
research agenda.
Further sessions revisited the themes revealed in this first
session. Overall, I would frame the main issues as follows:
-
Critics of biotechnology and/or the regulatory system
attempted to show that the main problem lies in the
“narrow approach” of governments to assess risk
or in the “unwillingness” of the governments and
industry to answer clear questions. The vagueness of the PP
is not a major issue.
-
Advocates of biotechnology and defenders of the current
regulatory systems attempted to show that the main issue is
the lack of public understanding (in concert with the
misinformation provided by some NGO’s). The vagueness
of the PP is seen as a major problem. The industry does not
like the PP because it makes the regulatory system presently,
or perhaps even permanently, less predictable (the PP is
difficult to define narrowly and even broad definitions have
not yet been fully agreed to).
Two aphorisms, both stated during the conference, may illustrate
these positions succinctly:
-
Critics of biotechnology: “Look before you
leap.”
-
Advocates of biotechnology: “Everybody wants
progress, nobody wants change.”
The issues becomes more complex, however, once the international
dimension is added. I would summarize the additional concerns as
follows:
-
Internationally, on the one hand, critics of biotechnology
try to show that the risks of biotechnology are real and that
producers have a responsibility to do a better job
understanding these risks. Further, one participants argued
that the proportionally representative democracies in Europe
are “more democratic” than the US and that,
therefore, controversial issues surface more readily in
European politics.
-
On the other hand, participants from lesser developed nations
made it very clear that hidden protectionism is a
major threat to their economies and that very poor
people live a life-style which often requires taking
extremely high risks (for example, recycling used syringes
from hospitals found on garbage deposits). One industry
participant provided the following challenge: “Does the
application of the PP produce an unfair advantage for the
developed world in any reasonable use of it?”
-
Diverging Use of the PP in Different
Countries
The principal conflict in the use of the PP is between Europe
and North America. This conference, however, did not focus on
how exactly the models differ. A presentation from the
Netherlands, for example, presented risk evaluation procedures
which looked very reasonable from a North American perspective.
However, many participants from the US criticized the European
Commission’s Communication from the Commission on the
Precautionary Principle (Brussels, 2 February 2000) but it
is not clear to me how the systems will precisely differ once
fully implemented. Perhaps the conflict is not so much among
regulators of different nations but rather between public
representatives and the established regulatory systems. By this
I mean that regulatory procedures among OECD countries are
already streamlined in a way which does allow for entirely
different conceptions of the PP. However, the validity of these
regulatory procedures, and the willingness of the public and
politicians to call them into doubt, seems to differ among
nations. Note that my perception is somewhat speculative, would
require more research, and was not explicitly stated at the
conference.
Participants from lesser developed countries showed that not
only risk-taking may differ among cultures, but that risk
assessments may also vary because of different environmental
conditions. The autonomy of nations was stressed several times.
-
Effect on Lesser Developed Nations
The effect of the use of diverging models for the interpretation
and application of the PP on lesser developed nations can only
be speculation at this point. Much will depend on the quality of
the decisions delivered by competing regulatory systems. The
full assessment of who is correct when it comes to the hazards
to human health, the environment, and society will require a
number of years.
However, it was argued that protectionism could be very harmful
to lesser developed nations. The trade official representing
Argentina was seriously worried about the possibility that
protectionism will surface disguised as precaution (that the PP
will override phyto-sanitary regulations under WTO). In the
past, Argentina used a form of the PP by not giving
registrations while there were on-going international
controversies over a given product. He framed the dilemma as
follows: (1) there is support for the PP in the sense of an
environmental protection regulation but (2) there is distrust of
the PP if implemented by trade officials.
In my own presentation I argued for transparency in the debate
over and implementation of the PP. This is a moral duty that
developed nations should assume because the less developed
nations do not have access to the inside-track of debates under
OECD and the detailed workings of our regulatory systems. Lesser
developed nations may be capable of assessing and managing risk
of products, but they cannot assess the quality of our work if
we lack transparency.
-
Outlook and Recommendation
I believe there is a real chance that the debate over the
precautionary principle will mimic the older debate over
“sustainable development.” There is a risk of having
a counter-productive outcome and, as a consequence, the
management of the debate may be very important.
Why is there so much debate over the PP? I would argue that the
nature of the debate which involves scientists, policy makers,
economists, specialists in international trade and many
nongovernment organizations illustrates that the precautionary
principle is the focal point of the debate over
the role of the World Trade Organization and over the issue of
how to deal with values in an otherwise science-based system.
It would take much work to summarize what already has been done
internationally on the conception and application of the PP. We
should also note that much is still in movement. Official
statements from regulatory bodies have been issued but the trade
issues around these statements may lead to modifications in the
future or may affect the implementation of the statements.
Therefore, a careful summary of the international literature may
not be the best approach to the understanding of the important
issues.
However, an assessment of the Canadian situation (the
perspective from our public, governments and industry) may be
necessary in order to be prepared to engage in the on-going
global debate. In public consultation, one should be open to
suggestions about the regulatory system in general and about how
the PP is to be conceived and embedded. However, such comments
could only be expected from a small portion of the public
familiar with technical issues in risk assessment. A more
complete public consultation requires the identification of the
fundamental values (and world-views) held by the public. An
understanding of what is being valued by the public (who
represent the principal risk-bearers) provides guidance for
which conception and level of the PP is the most appropriate in
the Canadian situation.
Recommendation:
I believe that the core issue is neither scientific in nature
nor purely political. In my (biased) opinion, the key to
understanding is (1) the analysis of the underlying
value-frameworks, (2) the expression of these value-frameworks
in a systematic and clear language and (3) the implementation of
a dialogue among all stakeholders with the goal to find means of
the convergence of policy recommendations. A model for such a
dialogue can be found in a paper recently commissioned by CBAC
(Paul Thompson, “Food and Agricultural Biotechnology:
Incorporating Ethical Considerations,” Draft, June
26, 2000). Such a dialogue, I would argue, should make use of
the systematic and clear language developed during the analysis
and strive towards convergence of policy recommendations rather
than reconciliation of underlying value-frameworks (the latter,
I believe, is too ambitious a goal).
|